Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 -27.55M
September 30, 2023 -23.26M
June 30, 2023 -36.89M
March 31, 2023 -35.71M
December 31, 2022 -36.58M
September 30, 2022 -16.08M
June 30, 2022 -26.68M
March 31, 2022 -32.01M
December 31, 2021 -35.69M
September 30, 2021 -29.28M
June 30, 2021 -21.55M
March 31, 2021 -20.48M
December 31, 2020 18.84M
September 30, 2020 -6.575M
June 30, 2020 -16.64M
March 31, 2020 -18.28M
December 31, 2019 1.050M
September 30, 2019 -12.94M
June 30, 2019 -6.936M
March 31, 2019 -15.35M
December 31, 2018 87.06M
September 30, 2018 -11.05M
Date Value
June 30, 2018 -9.788M
March 31, 2018 -8.695M
December 31, 2017 -4.709M
September 30, 2017 -10.18M
June 30, 2017 -7.000M
March 31, 2017 -7.804M
December 31, 2016 -7.091M
September 30, 2016 -9.381M
June 30, 2016 -9.842M
March 31, 2016 -9.529M
December 31, 2015 -4.495M
September 30, 2015 -7.611M
June 30, 2015 -4.301M
March 31, 2015 -4.469M
December 31, 2014 -7.302M
September 30, 2014 -2.276M
June 30, 2014 -6.077M
March 31, 2014 1.223M
December 31, 2013 -3.042M
September 30, 2013 3.530M
June 30, 2013 -5.171M
March 31, 2013 -3.072M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-36.89M
Minimum
Jun 2023
18.84M
Maximum
Dec 2020
-20.17M
Average
-21.55M
Median
Jun 2021

Free Cash Flow (Quarterly) Benchmarks

InflaRx NV -16.17M
MorphoSys AG --
BioNTech SE -493.35M
Immatics NV -45.38M
CureVac NV -61.17M